Barry Jutten

7.0k total citations
19 papers, 804 citations indexed

About

Barry Jutten is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Barry Jutten has authored 19 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Barry Jutten's work include Autophagy in Disease and Therapy (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Barry Jutten is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Endoplasmic Reticulum Stress and Disease (4 papers). Barry Jutten collaborates with scholars based in Netherlands, Canada and Belgium. Barry Jutten's co-authors include Kasper M.A. Rouschop, Bradly G. Wouters, Philippe Lambin, Guido Lammering, Marc Vooijs, Jan Theys, Arjan J. Groot, R. Habets, Ludwig J. Dubois and Kim G.M. Savelkouls and has published in prestigious journals such as Journal of Biological Chemistry, Blood and British Journal of Cancer.

In The Last Decade

Barry Jutten

19 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry Jutten Netherlands 17 442 266 209 192 106 19 804
Colin Rae United Kingdom 17 309 0.7× 226 0.8× 200 1.0× 80 0.4× 92 0.9× 27 636
Timothy G. Whitsett United States 18 527 1.2× 266 1.0× 247 1.2× 69 0.4× 239 2.3× 35 996
Patrick Bhola United States 11 467 1.1× 139 0.5× 184 0.9× 87 0.5× 108 1.0× 15 820
Benedetta Donati Italy 19 700 1.6× 125 0.5× 244 1.2× 426 2.2× 139 1.3× 43 1.4k
Aswin Abraham Canada 11 376 0.9× 136 0.5× 205 1.0× 72 0.4× 98 0.9× 30 718
Sriparna Ghosh United States 12 372 0.8× 238 0.9× 225 1.1× 125 0.7× 64 0.6× 16 717
T J Collard United Kingdom 17 706 1.6× 373 1.4× 263 1.3× 191 1.0× 93 0.9× 29 1.1k
Jiao Ji China 11 618 1.4× 238 0.9× 216 1.0× 338 1.8× 103 1.0× 23 1.0k

Countries citing papers authored by Barry Jutten

Since Specialization
Citations

This map shows the geographic impact of Barry Jutten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry Jutten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry Jutten more than expected).

Fields of papers citing papers by Barry Jutten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry Jutten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry Jutten. The network helps show where Barry Jutten may publish in the future.

Co-authorship network of co-authors of Barry Jutten

This figure shows the co-authorship network connecting the top 25 collaborators of Barry Jutten. A scholar is included among the top collaborators of Barry Jutten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry Jutten. Barry Jutten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jutten, Barry, et al.. (2023). Hypoxia-tolerant apical-out intestinal organoids to model host-microbiome interactions. Journal of Tissue Engineering. 14. 1768639512–1768639512. 19 indexed citations
2.
Jutten, Barry, Tom G. Keulers, Marco B.E. Schaaf, et al.. (2018). EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition. Autophagy. 14(2). 283–295. 37 indexed citations
3.
Schaaf, Marco B.E., Barry Jutten, Tom G. Keulers, et al.. (2015). Canonical autophagy does not contribute to cellular radioresistance. Radiotherapy and Oncology. 114(3). 406–412. 20 indexed citations
4.
Keulers, Tom G., Marco B.E. Schaaf, Kim G.M. Savelkouls, et al.. (2015). GABARAPL1 is required for increased EGFR membrane expression during hypoxia. Radiotherapy and Oncology. 116(3). 417–422. 20 indexed citations
5.
Buijsen, Jeroen, Jørgen van den Bogaard, Barry Jutten, et al.. (2015). A phase I–II study on the combination of rapamycin and short course radiotherapy in rectal cancer. Radiotherapy and Oncology. 116(2). 214–220. 22 indexed citations
6.
Schaaf, Marco B.E., Dan Cojocari, Tom G. Keulers, et al.. (2013). The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia. Radiotherapy and Oncology. 108(3). 529–534. 38 indexed citations
7.
Jutten, Barry & Kasper M.A. Rouschop. (2013). EGFR signaling and autophagy dependence for growth, survival, and therapy resistance. Cell Cycle. 13(1). 42–51. 97 indexed citations
8.
Jutten, Barry, Tom G. Keulers, Marco B.E. Schaaf, et al.. (2013). EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival. Radiotherapy and Oncology. 108(3). 479–483. 36 indexed citations
9.
Beucken, Twan van den, Michaël G. Magagnin, Barry Jutten, et al.. (2011). Translational control is a major contributor to hypoxia induced gene expression. Radiotherapy and Oncology. 99(3). 379–384. 36 indexed citations
10.
Theys, Jan, Barry Jutten, R. Habets, et al.. (2011). E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells. Radiotherapy and Oncology. 99(3). 392–397. 185 indexed citations
11.
Jutten, Barry, Ludwig J. Dubois, Hugo J.W.L. Aerts, et al.. (2009). Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells. Radiotherapy and Oncology. 92(3). 393–398. 32 indexed citations
12.
Theys, Jan, Barry Jutten, Ludwig J. Dubois, et al.. (2009). The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment. Radiotherapy and Oncology. 92(3). 399–404. 19 indexed citations
13.
Beucken, Twan van den, Marianne Koritzinsky, Hanneke E.C. Niessen, et al.. (2009). Hypoxia-induced Expression of Carbonic Anhydrase 9 Is Dependent on the Unfolded Protein Response. Journal of Biological Chemistry. 284(36). 24204–24212. 53 indexed citations
14.
Sluimer, Judith C., Inge Hamming, Harry van Goor, et al.. (2008). Angiotensin‐converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. The Journal of Pathology. 215(3). 273–279. 92 indexed citations
15.
Magagnin, Michaël G., Kjell Sergeant, Twan van den Beucken, et al.. (2007). Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress. Radiotherapy and Oncology. 83(3). 340–345. 16 indexed citations
16.
Weppler, Sherry A., Ludwig J. Dubois, Natasja G. Lieuwes, et al.. (2007). Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance. Radiotherapy and Oncology. 83(3). 333–339. 40 indexed citations
17.
Aerts, Hugo J.W.L., Ludwig J. Dubois, Tilman M. Hackeng, et al.. (2007). Development and evaluation of a cetuximab-based imaging probe to target EGFR and EGFRvIII. Radiotherapy and Oncology. 83(3). 326–332. 23 indexed citations
18.
Bijnens, Ann Pascale, Barry Jutten, Birgit Faber, et al.. (2003). Vasculin, a novel vascular protein differentially expressed in human atherogenesis. Blood. 102(8). 2803–2810. 12 indexed citations
19.
Scheffer, G L, Anneke W. Reurs, Barry Jutten, et al.. (2002). Selection and characterisation of a phage-displayed human antibody (Fab) reactive to the lung resistance-related major vault protein. British Journal of Cancer. 86(6). 954–962. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026